CSL Combines with Aventis to Create ZLB Behring
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 44 (Table of Contents)
Published: 4 Feb-2004
DOI: 10.3833/pdr.v2004.i44.832 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
CSL acquired Aventis Behring, the blood products business of Aventis, in a deal that has rendered CSL the industry’s second largest manufacturer of plasma products...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.
RSS